Respironics

Respironics is a global healthcare company specializing in the design, manufacture, and distribution of medical devices and therapies focused on respiratory care and sleep disorders. Founded in 1980, the company is headquartered in Murrysville, Pennsylvania, USA, and operates in over 100 countries. Respironics is a subsidiary of Philips Healthcare, which acquired the company in 2018 for approximately $16 billion.

The company is best known for its range of sleep apnea treatment solutions, including continuous positive airway pressure (CPAP) machines, which help patients with obstructive sleep apnea maintain open airways during sleep. Respironics also produces other respiratory devices, such as bilevel positive airway pressure (BiPAP) machines, ventilators, and humidifiers. These products are designed to improve patient outcomes by enhancing breathing efficiency and comfort.

In addition to hardware, Respironics offers software and cloud-based solutions for remote patient monitoring and data analytics. These tools enable healthcare providers to track patient progress, adjust treatments, and improve overall care delivery. The company collaborates with medical professionals, insurers, and patients to develop innovative therapies tailored to individual needs.

Respironics has received numerous industry accolades for its commitment to research and development, as well as its focus on patient-centered design. The company emphasizes clinical innovation, sustainability, and ethical business practices. Its products are widely used in hospitals, clinics, and home healthcare settings worldwide.

Beyond its core medical devices, Respironics has expanded into related healthcare technologies, including digital health solutions and connected care platforms. The company continues to invest in emerging areas such as artificial intelligence and telemedicine to enhance respiratory care accessibility and effectiveness.